中国香港特别行政区2022年1月6日至3月21日COVID-19死亡率与疫苗接种覆盖率
2022年1月6日至3月21日香港第五波奥密克戎疫情报告1,049,959例病例和5,906例死亡,死亡率37.7/百万人口为全球最高之一。截至2021年12月23日,≥60岁人群仅49%完成2剂接种,≥80岁仅18%。5,906例死亡中96%为≥60岁,其中70%未接种;≥60岁未接种者死亡风险是接种2-3剂者的21.3倍。
要点
- 香港第五波疫情期间COVID-19死亡率37.7/百万人口,为全球最高之一。
- 截至2021年12月23日,≥60岁人群2剂接种率49%,≥80岁仅18%。
- ≥60岁未接种者COVID-19死亡风险是接种2-3剂者的21.3倍。
核心结论
- 2022年香港奥密克戎疫情的高总体死亡率主要由≥60岁未接种疫苗人群的死亡驱动。
- 识别并解决年龄别疫苗接种覆盖率差距有助于预防COVID-19高死亡率,尤其是≥60岁人群。
研究设计与样本
- 分析香港公开的年龄别疫苗接种覆盖率数据(截至2021年12月23日)和2022年1月6日至3月21日COVID-19死亡数据。
- 疫苗接种包括2剂基础免疫程序:Sinovac-CoronaVac(科兴)灭活疫苗推荐≥3岁人群,BNT162b2(辉瑞-BioNTech)mRNA疫苗推荐≥5岁人群。
主要发现
- 2022年1月6日至3月21日香港报告1,049,959例COVID-19病例和5,906例COVID-19相关死亡,死亡率为37.7/百万人口。
- 截至2021年12月23日,香港67%符合接种条件者接种≥1剂、64%接种≥2剂、5%接种加强剂;≥60岁人群分别为52%、49%、7%。
- ≥60岁人群接种覆盖率随年龄下降:70-79岁≥1剂48%、≥2剂45%、加强剂7%;≥80岁≥1剂20%、≥2剂18%、加强剂2%。
- 5,906例死亡中5,655例(96%)为≥60岁人群;其中3,970例(70%)未接种、1,023例(18%)接种1剂、662例(12%)接种≥2剂。
- ≥60岁未接种、接种1剂、接种≥2剂者的COVID-19相关死亡率分别为10,076、1,099、473/百万人口;未接种者死亡风险是接种2-3剂者的21.3倍。
临床怎么用
- 识别并解决年龄别疫苗接种覆盖率差距,有助于预防COVID-19高死亡率,尤其是≥60岁人群。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
On January 6, 2022, a cluster of COVID-19 cases* caused by the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, was detected in Hong Kong Special Administrative Region, China (Hong Kong), resulting in the territory's fifth wave of COVID-19 cases (1). This wave peaked on March 4, 2022, with 8,764 COVID-19 cases per million population (2), resulting in a total of 1,049,959 cases and 5,906 COVID-19-associated deaths reported to the Hong Kong Department of Health during January 6-March 21, 2022.† Throughout this period, the COVID-19 mortality rate in Hong Kong (37.7 per million population) was among the highest reported worldwide since the COVID-19 pandemic began (3). Publicly available data on age-specific vaccination coverage in Hong Kong with a 2-dose primary vaccination series (with either Sinovac-CoronaVac [Sinovac], an inactivated COVID-19 viral vaccine, recommended for persons aged ≥3 years or BNT162b2 [Pfizer-BioNTech], an mRNA vaccine, for persons aged ≥5 years), as of December 23, 2021,§,¶ and COVID-19 mortality during January 6-March 21, 2022, were analyzed. By December 23, 2021, 67% of vaccine-eligible persons in Hong Kong had received ≥1 dose of a COVID-19 vaccine, 64% had received ≥2 doses, and 5% had received a booster dose. Among persons aged ≥60 years, these proportions were 52%, 49%, and 7%, respectively. Among those aged ≥60 years, vaccination coverage declined with age: 48% of persons aged 70-79 years had received ≥1 dose, 45% received ≥2 doses, and 7% had received a booster, and among those aged ≥80 years, 20%, 18%, and 2% had received ≥1 dose, ≥2 doses, and a booster dose, respectively. Among 5,906 COVID-19 deaths reported, 5,655 (96%) occurred in persons aged ≥60 years**; among these decedents, 3,970 (70%) were unvaccinated, 18% (1,023) had received 1 vaccine dose, and 12% (662) had received ≥2 doses. The overall rates of COVID-19-associated mortality among persons aged ≥60 years who were unvaccinated, who had received 1 COVID-19 vaccine dose, and who had received ≥2 vaccine doses were 10,076, 1,099, and 473 per million population, respectively; the risk for COVID-19-associated death among unvaccinated persons was 21.3 times that among recipients of 2-3 doses in this age group. The high overall mortality rate during the ongoing 2022 Hong Kong Omicron COVID-19 outbreak is being driven by deaths among unvaccinated persons aged ≥60 years. Efforts to identify and address gaps in age-specific vaccination coverage can help prevent high mortality from COVID-19, especially among persons aged ≥60 years.
引用
- Smith DJ, Hakim AJ, Leung GM, et al. COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35421076. doi:10.15585/mmwr.mm7115e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。